Search Orphan Drug Designations and Approvals
-
Generic Name: | Bacillus subtilis oxalate decarboxylase |
---|---|
Date Designated: | 02/29/2016 |
Orphan Designation: | Treatment of pediatric hyperoxaluria |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Allena Pharmaceuticals, Inc. 1 Executive Park Drive Suite 202 Newton, Massachusetts 02462 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-